Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Efficacy and safety of immune checkpoint inhibitors in Proficient Mismatch Repair (pMMR)/ Non-Microsatellite Instability-High (non-MSI-H) metastatic colorectal cancer: a study based on 39 cohorts incorporating 1723 patients

Fig. 2

The pooled objective response rate (ORR) of immune checkpoint inhibitors (ICIs) in proficient mismatch repair (pMMR)/non-microsatellite instability-high (non-MSI-H) metastatic colorectal cancer (mCRC): a forest plot and b funnel plot; and the pooled disease control rate (DCR) of ICIs in pMMR/non-MSI-H mCRC: c forest plot and d funnel plot

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us